Aurora Spine Corporation (ASAPF)
Stock analysis · OTC · Healthcare · Medical - Devices
Aurora Spine Corporation (ASAPF) is a publicly traded company in the Healthcare sector. Latest price: $0.08. Market cap $6.36M. Trailing PE -5.58. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About Aurora Spine Corporation
Aurora Spine Corporation, operating through its subsidiary Aurora Spine, Inc., specializes in the development and distribution of advanced, minimally invasive spine fusion systems and related medical devices. The company's diverse product portfolio includes a range of interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 lines, specifically engineered to treat patients suffering from degenerative disc diseases. Additionally, Aurora Spine provides titanium-coated polyether ether ketone (PEEK) interbody cages. These cages are crucial for maintaining proper spacing and stability between spinal vertebrae, thereby encouraging bone growth to achieve successful fusion. Aurora Spine also supplies sterile, titanium plasma spray coated spinal implants designed to promote bone integration. Complementing these, it offers a suite of interbody products such as the EOS, VOX, Echo, Echo SD, and EchoXL series for lumbar applications, and the Discovery system for cervical surgeries. Among its innovations is SOLO, a 3D-printed, stand-alone anterior lumbar interbody fusion device. This integrated plate and spacer system is designed to maintain the spine's natural…
Valuation
| P/E (TTM) | -5.58× |
|---|---|
| P/S (TTM) | 0.39× |
| P/B | 2.38× |
| PEG | 0.05× |
| P/FCF (TTM) | 21.76× |
| EV / EBITDA | 38.36× |
| EV / Sales | 0.49× |
| Earnings Yield | -18.01% |
| Free Cash Flow Yield | 4.60% |
Fundamentals
| Enterprise Value | $8.51M |
|---|---|
| Revenue (TTM) | $17.38M |
| Net Income (TTM) | -$1.21M |
| Free Cash Flow (TTM) | $643.49K |
| Net Debt | $1.80M |
| Working Capital | $3.66M |
| Gross Margin | 41.85% |
| Operating Margin | -4.98% |
| Net Margin | -6.95% |
| Return on Equity | -34.32% |
| Return on Invested Capital | -13.75% |
Peers
Recent News
- Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery
- Aurora Spine Corporation Announces Amendment to Loan from Insider
- Aurora Spine Corporation Announces Second Quarter FY26 Financial Results
- Aurora Spine Announces Settlement of Arbitration, New Patent License Agreement for SI Joint Product and Increase in Funding from Insider
Related
Browse more tickers: sitemap